NephLong
Renesis
Details
20 mg
50 mg
70 mg
100 mg
Generic Name: Roxadustat
Product Description:
Renesis Tablet contains Roxadustat, a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI). It is an oral medication used primarily for the treatment of anemia associated with chronic kidney disease (CKD) in both dialysis-dependent and non-dialysis-dependent patients. Roxadustat works by stimulating the body's natural pathway to increase erythropoietin production, improving iron metabolism, and enhancing red blood cell production.
Key Features:
-
Generic Name: Roxadustat
-
Indication: Treatment of anemia in CKD patients
-
Mechanism of Action: HIF-PHI – promotes erythropoiesis and improves iron utilization
-
Dosage Form: Tablet (available in various strengths as per clinical requirements)
-
Route: Oral administration
Keto Nephron™ DS is a Medical Food as defined under 21 U.S.C. §360ee(b)(3) and 21 CFR 101.9(j)(8), formulated for the dietary management of Chronic Kidney Disease (CKD) Stages 3-5 in adults following physician-supervised protein-restricted diets. It is not a drug, not a dietary supplement, and is not intended for self-medication or general wellness use. MUST BE USED UNDER MEDICAL SUPERVISION. Quantum LifeSciences Inc., Claremont, CA 91711, USA. FDA Food Facility (Manufacturer) Reg. No. 14961463490.